Cabozantinib in ovarian clear cell cancers: UnMET expectations.

Cabozantinib in ovarian clear cell cancers: UnMET expectations. Gynecol Oncol. 2018 Jul;150(1):1-2 Authors: Secord AA, Previs RA, Nixon AB PMID: 29935857 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/29935857?dopt=Abstract

Source: Gynecologic Oncology - June 27, 2018 Category: Cancer & Oncology Authors: Secord AA, Previs RA, Nixon AB Tags: Gynecol Oncol Source Type: research

More News: Cancer | Cancer & Oncology | Ovarian Cancer | Ovaries